Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
Authors:
- Francis A. MithenFMFrancis A. Mithen
- Marinos C. DalakasMDMarinos C. Dalakas
- Zi-Wei ChenZCZi-Wei Chen
- Stuart D. CookSCStuart D. Cook
- 1 January 1992
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 107 (1) , 111-121
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathyJournal of Neuroimmunology, 1989
- Identification and Characterization of Gangliosides Reacting with IgM Paraproteins in Three Patients with Neuropathy Associated with Biclonal GammopathyJournal of Neurochemistry, 1988
- Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1bAnnals of Neurology, 1988
- Serum antibodies to gangliosides in guillain‐barré syndromeAnnals of Neurology, 1988
- Plasma Exchange in Chronic Inflammatory Demyelinating PolyradiculoneuropathyNew England Journal of Medicine, 1986
- Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxinActa Neuropathologica, 1986
- Subcellular Fractionation of Rat Sciatic Nerve and Specific Localization of Ganglioside LM1 in Rat Nerve MyelinJournal of Neurochemistry, 1985
- The monoclonal antibody HNK-1 reacts with a human peripheral nerve gangliosideBiochemical and Biophysical Research Communications, 1984
- Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatmentAnnals of Neurology, 1981
- GANGLIOSIDES OF HUMAN MYELIN: SIALOSYLGALACTOSYLCERAMIDE (G7) AS A MAJOR COMPONENTJournal of Neurochemistry, 1973